真性红细胞增多症和原发性血小板增多症这两种骨髓增殖性疾病的流行病学
Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia.
作者信息
Johansson Peter
机构信息
Department of Hematology, Sahlgrenska University Hospital, Göteborg, Sweden.
出版信息
Semin Thromb Hemost. 2006 Apr;32(3):171-3. doi: 10.1055/s-2006-939430.
PMID:16673273
Abstract
The annual incidence of polycythemia vera (PV) and essential thrombocythemia (ET) is approximately 2 and 1.5 per 100,000 inhabitants, respectively, if based on large population surveys and adjusted to a standard population. Survival for ET patients does not differ from that of the general population. However, it appears that PV patients have a significantly higher mortality, at least for patients diagnosed before 1990.
摘要
真性红细胞增多症（PV）和原发性血小板增多症（ET）的年发病率，如果基于大规模人群调查并调整至标准人群，分别约为每10万居民2例和1.5例。ET患者的生存率与普通人群无异。然而，至少对于1990年前确诊的患者而言，PV患者的死亡率似乎显著更高。
Zotero 插件